Associate Professor, Department of Molecular and Human Genetics
Baylor College of Medicine, USA
Philip Ng is Associate Professor in the Department of Molecular and Human Genetics at Baylor College of Medicine. He received his BSc from the University of Toronto, and his MSc and PhD from the University of Guelph in Ontario, Canada. Dr. Ng was the recipient of the American Society of Gene and Cell Therapy’s Outstanding New Investigator Award in 2007. He serves on the Editorial Board for the journal Molecular Therapy, and has served as a reviewer for The NIH, Blood, Journal of Clinical Investigation, Molecular Therapy, Immunology and Cell Biology, Journal of Viriological Methods, Journal of Virology, The American Journal of Human Genetics, Human Gene Therapy, Biotechniques, Journal of Gene Medicine, BioMed Central Biotechnology, Gene Therapy, Journal of Molecular Endocrinology, Applied Biochemistry and Biotechnology, Biotechnology Progress, Nucleic Acids Research, Expert Opinions on Emerging Drugs, Hepatology. Dr. Ng has published over seventy peer-reviewed papers, review articles and book chapters in the field of gene therapy.
The innate and adaptive immune responses to HDAd. These important studies will provide information regarding the host-vector interactions which will be very useful for further improving the safety and efficacy of HDAd-mediated gene therapy.
Liver-directed gene therapy using HDAd to treat a wide variety of genetic disease such as hemophilia, Crigler-Najjar syndrome, cardiovascular disease, alpha 1-antitrypsin deficiency.